2014
DOI: 10.1182/blood-2013-09-402560
|View full text |Cite
|
Sign up to set email alerts
|

Extracellular nucleotide and nucleoside signaling in vascular and blood disease

Abstract: Nucleotides and nucleosides—such as adenosine triphosphate (ATP) and adenosine—are famous for their intracellular roles as building blocks for the genetic code or cellular energy currencies. In contrast, their function in the extracellular space is different. Here, they are primarily known as signaling molecules via activation of purinergic receptors, classified as P1 receptors for adenosine or P2 receptors for ATP. Because extracellular ATP is rapidly converted to adenosine by ectonucleotidase, nucleotide-pho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
109
0
3

Year Published

2016
2016
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 122 publications
(112 citation statements)
references
References 111 publications
0
109
0
3
Order By: Relevance
“…General schemes of purine-converting pathways include nucleoside triphosphate diphosphohydrolase-1 (NTPDase1, also known as CD39), other enzymes of NTPDase and nucleotide pyrophosphatase/phosphodiesterase families, ecto-5′-nucleotidase/CD73 (eN/CD73), alkaline phosphatases, adenosine deaminase, and backward ATP-regenerating enzymes adenylate kinase (AK) and nucleoside diphosphate kinase (NDPK) [19,21,22]. Research over the past decade highlights the central role for CD39-CD73 axis in controlling the balance between ATP, ADP, and adenosine in a wide range of diseases, including endothelial barrier dysfunction and activation and aggregation of platelets at sites of vascular injury, hypoxia, and inflammation [20,23,24]. However, current knowledge of regulatory pathways governing the duration and magnitude of purinergic signaling in the eye remains rather scattered.…”
Section: Introductionmentioning
confidence: 99%
“…General schemes of purine-converting pathways include nucleoside triphosphate diphosphohydrolase-1 (NTPDase1, also known as CD39), other enzymes of NTPDase and nucleotide pyrophosphatase/phosphodiesterase families, ecto-5′-nucleotidase/CD73 (eN/CD73), alkaline phosphatases, adenosine deaminase, and backward ATP-regenerating enzymes adenylate kinase (AK) and nucleoside diphosphate kinase (NDPK) [19,21,22]. Research over the past decade highlights the central role for CD39-CD73 axis in controlling the balance between ATP, ADP, and adenosine in a wide range of diseases, including endothelial barrier dysfunction and activation and aggregation of platelets at sites of vascular injury, hypoxia, and inflammation [20,23,24]. However, current knowledge of regulatory pathways governing the duration and magnitude of purinergic signaling in the eye remains rather scattered.…”
Section: Introductionmentioning
confidence: 99%
“…1,2,7,8,11,12,35) Previous studies have reported that the application of these substances results in vasoconstriction or vasodilatation and that the extent of these responses is altered in hypertensive arteries. 1,2,11,29) However, few studies have compared the vasorelaxant effect of these three substances in the same region of arteries from hypertensive subjects.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4][5][6][7][8][9][10] They also exert a variety of effects on the vasculature, such as platelet activation and alteration in smooth muscle contraction and relaxation, by activating plasmalemmal receptors (e.g., purinoceptors). 1,2,8,11,12) Purinoceptors are classified into two subtypes, namely P1 and P2, based on their pharmacological properties and molecular cloning characteristics.…”
mentioning
confidence: 99%
“…Extracellular nucleotides such as ATP, ADP, and AMP, and their nucleoside derivative adenosine, are signaling compounds involved in several biological processes, including inflammation and immune responses [16]. While ATP acts as a Bfind-me signal^that conducts phagocytes to inflammatory sites, its breakdown product adenosine contributes to the engineering of inflammation and immune responses by providing a suppressive tissueprotecting signal [17].…”
Section: Introductionmentioning
confidence: 99%